MESO
Mesoblast limited.

5,282
Mkt Cap
$2.36B
Volume
254,164.00
52W High
$21.50
52W Low
$9.61
PE Ratio
-21.64
MESO Fundamentals
Price
$16.89
Prev Close
$18.30
Open
$17.63
50D MA
$18.16
Beta
1.43
Avg. Volume
223,729.50
EPS (Annual)
-$0.8443
P/B
3.92
Rev/Employee
$211,960.04
$1,281.89
Loading...
Loading...
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
81

Frequently Asked Questions

What is Market Cap of Mesoblast Ltd - ADR?
What is the 52-week high for Mesoblast Ltd - ADR?
What is the 52-week low for Mesoblast Ltd - ADR?
What is Mesoblast Ltd - ADR stock price today?
What was Mesoblast Ltd - ADR stock price yesterday?
What is the PE ratio of Mesoblast Ltd - ADR?
What is the Price-to-Book ratio of Mesoblast Ltd - ADR?
What is the 50-day moving average of Mesoblast Ltd - ADR?
How many employees does Mesoblast Ltd - ADR have?

Latest MESO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.